Recently, strong evidence has associated ROR1 expression with cancer stem cells (CSCs), epithelial–mesenchymal transition (EMT) and chemoresistance, making this receptor a critical factor in tumor metastasis and recurrence [29,30]. Here, ROR1 is linked to cancer.